Welcome to LookChem.com Sign In|Join Free

CAS

  • or

163277-80-3

Post Buying Request

163277-80-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

163277-80-3 Usage

General Description

Ac-Thr(t-Bu)-OH is a threonine derivative.

Check Digit Verification of cas no

The CAS Registry Mumber 163277-80-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,6,3,2,7 and 7 respectively; the second part has 2 digits, 8 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 163277-80:
(8*1)+(7*6)+(6*3)+(5*2)+(4*7)+(3*7)+(2*8)+(1*0)=143
143 % 10 = 3
So 163277-80-3 is a valid CAS Registry Number.

163277-80-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (806528)  Ac-Thr(t-Bu)-OH  

  • 163277-80-3

  • 806528-250MG

  • 931.32CNY

  • Detail

163277-80-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S,3R)-2-Acetamido-3-(tert-butoxy)butanoic acid

1.2 Other means of identification

Product number -
Other names (2S,3R)-2-acetamido-3-[(2-methylpropan-2-yl)oxy]butanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:163277-80-3 SDS

163277-80-3Downstream Products

163277-80-3Relevant articles and documents

General Fmoc-Based Solid-Phase Synthesis of Complex Depsipeptides Circumventing Problematic Fmoc Removal

Lobo-Ruiz, Ariadna,Tulla-Puche, Judit

supporting information, p. 183 - 192 (2020/01/24)

Development of an Fmoc-based solid-phase depsipeptide methodology has been hampered by base-promoted fragmentation and diketoperazine formation upon Fmoc group elimination. Such a strategy would be a useful tool given the number of commercially available Fmoc-protected residues. Herein we report that the addition of small percentages of organic acids to the Fmoc-removal cocktail proves effective to circumvent these drawbacks and most importantly, allowed the development of an exclusively solid-phase stepwise methodology to prepare a highly complex depsipeptide with multiple and consecutive esters bonds. Alongside, the optimal protecting group scheme for residue incorporation, which is not as straightforward as it is for traditional peptide synthesis, was explored. The developed stepwise strategy proved effective for the synthesis of a highly complex cyclodepsipeptide, being comparable to the yields obtained when using traditional combined chemistry approaches.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 163277-80-3